SCHEMBL16506229

SCHEMBL16506229

NC(=O)c1nc(-c2cc(Br)ccc2F)ccc1NC1COC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 3/20 0.35
▸ SYK P43405 3/20 0.35
▸ PIM3 Q86V86 2/20 0.35
▸ PIM2 Q9P1W9 2/20 0.35
▸ KCNH2 Q12809 2/20 0.35
▸ DGAT1 O75907 1/20 0.35
▸ MAP2K3 P46734 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ MAP2K2 P36507 1/20 0.32
▸ MAP2K1 Q02750 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ MAP3K14 Q99558 1/20 0.31
▸ BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16505406 0.77 ROCK2 (0.39) SYKKCNH2BTKLRRK2ROCK2
SCHEMBL16505287 0.76 MAP2K3 (0.49) PIM1PIM3PIM2DGAT1MAP2K3
SCHEMBL16505826 0.76 LRRK2 (0.38) SYKKCNH2MAP2K3MAPK14BTK
SCHEMBL16506486 0.74 PTGER4 (0.39) MAP2K3MAPK14ALDH1A1MAP2K1
SCHEMBL16526461 0.74 MAP3K14 (0.33) MAP3K14
SCHEMBL16505002 0.73 MAP3K14 (0.60) MAP3K14
SCHEMBL16506022 0.69 ATR (0.47) PIM1PIM3PIM2DGAT1
SCHEMBL28627251 0.66 AAK1 (0.41) —
SCHEMBL16517590 0.65 PIM1 (0.33) PIM1PIM2ROCK2
SCHEMBL16516878 0.64 ALDH1A1 (0.33) PIM1PIM2BTKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170210724-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2017-07-27 — — US disclosed
US-20170210724-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2017-07-27 — — US disclosed
US-20160185797-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2016-06-30 — — US disclosed
EP-3036229-A1 ALKYNYL ALCOHOLS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2016-06-29 — — EP disclosed
WO-2015025026-A1 ALKYNYL ALCOHOLS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2015-02-26 — — WO disclosed
WO-2015025026-A1 ALKYNYL ALCOHOLS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2015-02-26 — — WO disclosed
US-20150057260-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2015-02-26 — — US disclosed
US-20150057260-A1 ALKYNYL ALCOHOLS AND METHODS OF USE GENENTECH, INC. (US) 2015-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057260-A1 ALKYNYL ALCOHOLS AND METHODS OF USE NFKB2, NFKB1, NFKBIA PIM1 3403/4885SYK 1698/4885PIM3 3985/4885
US-20170210724-A1 ALKYNYL ALCOHOLS AND METHODS OF USE NFKB2, NFKB1, NFKBIA PIM1 3403/4885SYK 1698/4885PIM3 3985/4885
US-20160185797-A1 ALKYNYL ALCOHOLS AND METHODS OF USE NFKB2, NFKB1, NFKBIA PIM1 3403/4885SYK 1698/4885PIM3 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback